Plasma Glucose at Hospital Admission and Previous Metabolic Control Determine Myocardial Infarct Size and Survival in Patients With and Without Type 2 Diabetes-Reference-Cited by-同舟云学术

Plasma Glucose at Hospital Admission and Previous Metabolic Control Determine Myocardial Infarct Size and Survival in Patients With and Without Type 2 Diabetes

Published:2005-10-01 Issue:10 Volume:28 Page:2551-2553
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Meier Juris J.¹²,Deifuss Silvia¹,Klamann Andreas¹,Launhardt Volker¹,Schmiegel Wolff H.¹,Nauck Michael A.¹³

Affiliation:

1. Department of Medicine, Ruhr-University, Knappschafts-Krankenhaus, Bochum, Germany

2. Larry Hillblom Islet Research Center, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California

3. Diabeteszentrum Bad Lauterberg im Harz, Bad Lauterberg, Germany

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/28/10/2551/566559/zdc01005002551.pdf

Reference10 articles.

1. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS: Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J 293:917–922, 1986

2. O’Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R: In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 14:758–760, 1991

3. Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Int Med 126:296–306, 1997

4. Klamann A, Sarfert P, Schulte G, Launhardt V, Schmiegel W, Nauck MA: Myocardial infarction in diabetic versus non-diabetic subjects: relation of survival and infarct size following therapy with sulfonylureas (glibenclamide). Eur Heart J 21:220–229, 2000

5. Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality on conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632, 1999

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Hyperglycemia-Induced Injury in Myocardial Infarction;International Journal of Molecular Sciences;2024-08-04

2. Perioperatives Management bei Patienten mit Diabetes mellitus;Gefäßmedizin Scan - Zeitschrift für Angiologie, Gefäßchirurgie, diagnostische und interventionelle Radiologie;2023-09

3. Glycemic Management in Coronary Artery Bypass Graft Patients;Contemporary Endocrinology;2023

4. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA;Cardiovascular Diabetology;2021-09-24

5. Glucose fluctuations and hypoglycemia as new cardiovascular risk factors in diabetes;Annales d'Endocrinologie;2021-06